about
Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice.New technologies - new insights into the pathogenesis of hepatic encephalopathy.Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.Expression of a smaller lecithin:retinol acyl transferase transcript and reduced retinol esterification in MCF-7 cells.Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinomaA combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.Circulating microRNAs Reveal Time Course of Organ Injury in a Porcine Model of Acetaminophen-Induced Acute Liver FailureExtracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical studyPyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancerMUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.Cell death markers in cirrhotic patients with acute decompensation.Human melanomas of fibroblast and epithelial morphology differ widely in their ability to synthesize retinyl esters.Retinoic acid and 4-hydroxyphenylretinamide induce growth inhibition and tissue transglutaminase through different signal transduction pathways in mouse fibroblasts (NIH 3T3 cells).Role of aquaporin-4 in the development of brain oedema in liver failure.Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion.Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro.Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension.Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure.Mechanism of cell death in acute-on-chronic liver failure: a clinico-pathologic-biomarker study.Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis.Differences in uptake and metabolism of retinoic acid between estrogen receptor-positive and -negative human breast cancer cellsExogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH
P50
Q31026783-1335A3A5-E44B-46E0-9502-60D330E8218CQ31134437-DBEEEDB6-325F-44C8-882F-9B440151F441Q31170767-262E8F14-C763-4604-844C-633B75EB497EQ33931958-510AC027-73B1-41F9-A2F2-8B0188CF4A83Q34102283-141CF0FF-6B64-46BC-8C34-2A8ACFE29FF9Q35620650-4A8D8400-CE9F-46E4-96DE-BFA3A6E3BDE5Q35643888-5085BA4A-B75E-42E8-B609-298137B83760Q35970399-344DAFBD-BE45-4798-A82F-3037B7497A0EQ36381459-2192F4E9-EB49-4DC1-B092-0BD60853A4F0Q36667483-288CEC77-910C-474E-A824-3873D1707AA4Q37582071-64204C24-0B8B-417E-AEB3-4750925CF93BQ41986551-A70A8646-E3EB-4238-9591-2DFDAA01B166Q42527656-F30871E4-313F-44BD-BF63-B034E247B378Q42814896-82A19434-DCBE-4870-B2BC-A38C386056B9Q43069745-4E5CD6D2-62FD-4612-9FF1-7289E58D3C80Q44749290-6BE36B7C-526C-4DE8-9825-DF03CC29482CQ46454132-B8C6E4A9-BB93-4A23-97DA-A781C6CBE557Q46625717-CC1F774C-C072-4478-AD7E-AC9A1764B3E4Q46806637-247ACA41-5BDD-4130-B190-0AD6EC88BAC1Q50930732-D2FF9A39-C02F-413F-9F3F-B9CBE9F7B0A3Q51742077-FCD13C23-6221-47B4-ACDF-0C1BB76D8835Q74266060-4C425A63-763A-4E1B-A80E-D016A1BFCDCBQ95324834-22CD29D6-0F22-4C78-B425-D9CB8C6F51C9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fausto Andreola
@ast
Fausto Andreola
@en
Fausto Andreola
@es
Fausto Andreola
@nl
type
label
Fausto Andreola
@ast
Fausto Andreola
@en
Fausto Andreola
@es
Fausto Andreola
@nl
prefLabel
Fausto Andreola
@ast
Fausto Andreola
@en
Fausto Andreola
@es
Fausto Andreola
@nl
P106
P21
P31
P496
0000-0003-4926-0121